Bioactive Derivatives from Algae: Properties and Applications in Pharmaceuticals
Online veröffentlicht: 21. Sept. 2023
Seitenbereich: 438 - 449
Eingereicht: 30. März 2023
Akzeptiert: 15. Juni 2023
DOI: https://doi.org/10.2478/rtuect-2023-0032
Schlüsselwörter
© 2023 Anna Merlo et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Using algae metabolites is considered a current and innovative topic of interest. Among the various applying sectors such as food, manufacturing, and environment, these organisms are also characterized by a high therapeutic potential. The influence of biotic and abiotic factors allows the production of different bioactive compounds, such as carbohydrates, polyphenols, proteins, vitamins, sterols, fatty acids and many others. The algal biomass is investigated to discover and develop new possible therapies and nowadays different properties have been determined, like antioxidant, antiviral, antimicrobial, anti-inflammatory, antidiabetic. Typical examples include the application of algae in diabetes mellitus, which is a disease that is continually spreading throughout Europe and the world. Numerous trials are currently underway to develop innovative and effective treatments, as well as several algae are being investigated in order to gain a deeper understanding of this pathology. In recent studies it has been demonstrated that metabolites such as polyphenols, polysaccharides and pigments, by their inhibitory activity, are capable of reducing blood glucose levels and increasing the amount of insulin.